Among PDE inhibitors, the most extensively studied are PDE4 inhibitors such as rolipram and roflumilast.16-18 Notably, PDE4 inhibitors are not typically used for the treatment of AD due to their side effects such as nausea and vomiting.19 This evidence concerns the gene PDE4A and Alzheimer disease.